Ascletis Pharma Inc. (01672) Stock Discussion Board

01672 Ascletis Pharma Inc.ASCLETIS-BHong Kong Stock Exchange

10 posts

Price chart ・ Find other stocks ・ Japanese version

Ascletis Pharma Inc. (01672) at a glance

Code: 01672
Company: Ascletis Pharma Inc.
Local name: ASCLETIS-B
Market: Hong Kong Stock Exchange
Share price: HK$4.78 +0.01 (+0.21%) Nov 11 close

Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.

Ascletis Pharma Inc. (01672) Stock Price History

Ascletis Pharma Inc. closed at HK$4.78 on Nov 11, 2026, −31.4% over 1 month, −57.1% over 1 year.

1M3M6M1Y3Y5YAll

Price5-day MA25-day MAHang Seng IndexDisclosures

1-Month HighHK$6.84Oct 12

1-Month LowHK$4.31Nov 3

1-Week Change+4.6%vs Nov 4

1-Month Change−31.4%vs Oct 9

If you had invested HK$10,000 1 month ago, it would be worth HK$6,981 today (−30.2%).Price change only; dividends and fees are not included.

Over the same period the Hang Seng Index moved +0.2%, while this stock moved −30.2%.

Last 10 Trading Days

Date	Close	Change	% Change
Nov 11 (Wed)	HK$4.78	+0.01	+0.21%
Nov 10 (Tue)	HK$4.77	+0.06	+1.28%
Nov 9 (Mon)	HK$4.71	+0.16	+3.41%
Nov 6 (Fri)	HK$4.55	−0.35	−7.05%
Nov 5 (Thu)	HK$4.90	+0.33	+7.23%
Nov 4 (Wed)	HK$4.57	+0.26	+5.92%
Nov 3 (Tue)	HK$4.31	−0.45	−9.36%
Nov 2 (Mon)	HK$4.76	−0.15	−2.96%
Oct 30 (Fri)	HK$4.90	−0.32	−6.04%
Oct 29 (Thu)	HK$5.22	−0.22	−4.05%

Price5-day MA25-day MAHang Seng IndexDisclosures

3-Month HighHK$10.80Aug 12

3-Month LowHK$4.31Nov 3

1-Month Change−31.4%vs Oct 9

3-Month Change−55.4%vs Aug 11

If you had invested HK$10,000 3 months ago, it would be worth HK$4,463 today (−55.4%).Price change only; dividends and fees are not included.

Over the same period the Hang Seng Index moved −5.2%, while this stock moved −55.4%.

Last 10 Trading Days

Date	Close	Change	% Change
Nov 11 (Wed)	HK$4.78	+0.01	+0.21%
Nov 10 (Tue)	HK$4.77	+0.06	+1.28%
Nov 9 (Mon)	HK$4.71	+0.16	+3.41%
Nov 6 (Fri)	HK$4.55	−0.35	−7.05%
Nov 5 (Thu)	HK$4.90	+0.33	+7.23%
Nov 4 (Wed)	HK$4.57	+0.26	+5.92%
Nov 3 (Tue)	HK$4.31	−0.45	−9.36%
Nov 2 (Mon)	HK$4.76	−0.15	−2.96%
Oct 30 (Fri)	HK$4.90	−0.32	−6.04%
Oct 29 (Thu)	HK$5.22	−0.22	−4.05%

Price25-day MA75-day MAHang Seng IndexDisclosures

6-Month HighHK$17.28May 14

6-Month LowHK$4.31Nov 3

3-Month Change−55.4%vs Aug 11

6-Month Change−71.8%vs May 11

If you had invested HK$10,000 6 months ago, it would be worth HK$2,820 today (−71.8%).Price change only; dividends and fees are not included.

Over the same period the Hang Seng Index moved −7.9%, while this stock moved −71.8%.

Monthly Closes

Month	Month-End Close	Monthly %
Nov 2026	HK$4.78	−2.6%
Oct 2026	HK$4.90	−41.4%
Sep 2026	HK$8.37	−16.5%
Aug 2026	HK$10.02	+20.0%
Jul 2026	HK$8.35	−20.9%
Jun 2026	HK$10.56	−25.8%
May 2026	HK$14.23	−13.6%

Price25-day MA75-day MAHang Seng IndexDisclosures

52-Week HighHK$19.15Apr 24

52-Week LowHK$4.31Nov 3

Year to Date−58.1%vs Dec 31

From 52-Week High−75.1%Apr 24

If you had invested HK$10,000 1 year ago, it would be worth HK$4,290 today (−57.1%).Price change only; dividends and fees are not included.

Over the same period the Hang Seng Index moved −8.9%, while this stock moved −57.1%.

Monthly Closes

Month	Month-End Close	Monthly %
Nov 2026	HK$4.78	−2.6%
Oct 2026	HK$4.90	−41.4%
Sep 2026	HK$8.37	−16.5%
Aug 2026	HK$10.02	+20.0%
Jul 2026	HK$8.35	−20.9%
Jun 2026	HK$10.56	−25.8%
May 2026	HK$14.23	−13.6%
Apr 2026	HK$16.47	−1.0%
Mar 2026	HK$16.64	+5.6%
Feb 2026	HK$15.76	+14.2%
Jan 2026	HK$13.80	+21.1%
Dec 2025	HK$11.40	−22.1%
Nov 2025	HK$14.63	+51.6%

Price13-week MA26-week MAHang Seng Index

3-Year HighHK$19.15Apr 24, 2026

3-Year LowHK$0.78Aug 19, 2024

Annualized Return+37.5%

Max Drawdown−76.2%

If you had invested HK$10,000 3 years ago, it would be worth HK$25,951 today (+159.5%).Price change only; dividends and fees are not included.

Over the same period the Hang Seng Index moved +39.3%, while this stock moved +159.5%.

Yearly Closes

Year	Year-End Close	Yearly %
2026 (YTD)	HK$4.78	−58.1%
2025	HK$11.40	―

Price13-week MA26-week MAHang Seng Index

5-Year HighHK$19.15Apr 24, 2026

5-Year LowHK$0.78Aug 19, 2024

Annualized Return+9.8%

Max Drawdown−85.9%

If you had invested HK$10,000 5 years ago, it would be worth HK$15,970 today (+59.7%).Price change only; dividends and fees are not included.

Over the same period the Hang Seng Index moved −2.9%, while this stock moved +59.7%.

Yearly Closes

Year	Year-End Close	Yearly %
2026 (YTD)	HK$4.78	−58.1%
2025	HK$11.40	―

Price1-year MA2-year MAHang Seng Index

All-Time HighHK$19.15Apr 2026

All-Time LowHK$0.78Aug 2024

Total Change−52.3%vs Jul 2018

Annualized Return−8.6%

If you had invested HK$10,000 in Jul 2018, it would be worth HK$4,765 today (−52.3%).Price change only; dividends and fees are not included.

Over the same period the Hang Seng Index moved −12.8%, while this stock moved −52.3%.

Yearly Closes

Year	Year-End Close	Yearly %
2026 (YTD)	HK$4.78	−58.6%
2025	HK$11.52	+266.9%
2024	HK$3.14	+115.1%
2023	HK$1.46	−69.2%
2022	HK$4.74	+44.1%
2021	HK$3.29	+14.2%
2020	HK$2.88	−1.7%
2019	HK$2.93	−52.5%
2018	HK$6.17	―

Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Jul 2018). Please check the latest prices before trading.

Recent announcements (HKEXnews)

11/11 17:00 事業の状況 VOLUNTARY ANNOUNCEMENT - ASCLETIS SUBMITS IND APPLICATION TO THE U.S. FDA FOR ASC30_39 FDC, A POTENTIALLY FIRST-IN-CLASS ORAL SMALL MOLECULE FIXED-DOSE COMBINATION OF GLP-1R AGONIST AND SELECTIVE AMYLIN RECEPTOR AGONIST, FOR THE TREATMENT OF OBESITY

Posts

This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.

No.10 Disclosure 2026/11/11 18:00

事業の状況
VOLUNTARY ANNOUNCEMENT - ASCLETIS SUBMITS IND APPLICATION TO THE U.S. FDA FOR ASC30_39 FDC, A POTENTIALLY FIRST-IN-CLASS ORAL SMALL MOLECULE FIXED-DOSE COMBINATION OF GLP-1R AGONIST AND SELECTIVE AMYLIN RECEPTOR AGONIST, FOR THE TREATMENT OF OBESITY

📄 Open the filing

Delete

No.9 Disclosure 2026/11/04 23:01

株式報酬制度
GRANT OF SHARE OPTIONS

📄 Open the filing

Delete

No.8 Disclosure 2026/11/02 17:40

事業の状況
VOLUNTARY ANNOUNCEMENT - ASCLETIS TO PRESENT STUDY RESULTS OF ORAL SMALL MOLECULE GIPR AGONIST ASC48 AND GLP-1R/GIPR/GCGR TRIPLE PEPTIDE AGONIST ASC37 AT OBESITYWEEK 2026

📄 Open the filing

Delete

No.7 Disclosure 2026/10/29 08:30

事業の状況
VOLUNTARY ANNOUNCEMENT - ASCLETIS' ORAL SMALL MOLECULE GLP-1, ASC30, DEMONSTRATED PLACEBO-ADJUSTED HBA1C REDUCTION OF 1.7% AT 12 WEEKS FROM ITS U.S. PHASE II STUDY IN PARTICIPANTS WITH DIABETES

📄 Open the filing

Delete

No.6 Disclosure 2026/10/26 09:00

事業の状況
VOLUNTARY ANNOUNCEMENT - ASCLETIS ANNOUNCES FDA IND SUBMISSION OF ASC39, AN ORAL SMALL MOLECULE SELECTIVE AMYLIN RECEPTOR AGONIST FOR THE TREATMENT OF OBESITY

📄 Open the filing

Delete

No.5 Disclosure 2026/10/23 09:00

事業の状況
VOLUNTARY ANNOUNCEMENT - ASCLETIS' STRATEGIC PARTNER SAGIMET ANNOUNCES FIRST PATIENT DOSED IN PHASE III U.S. CLINICAL TRIAL OF DENIFANSTAT (ASC40) FOR MODERATE TO SEVERE ACNE

📄 Open the filing

Delete

No.4 Disclosure 2026/10/20 09:00

事業の状況
VOLUNTARY ANNOUNCEMENT - ASCLETIS ANNOUNCES POSITIVE PRECLINICAL DATA FOR THE MOST COMPREHENSIVE ONCE-WEEKLY ORAL PEPTIDE PIPELINE FOR THE TREATMENT OF OBESITY

📄 Open the filing

Delete

No.3 Disclosure 2026/10/02 17:50

事業の状況
VOLUNTARY ANNOUNCEMENT - ASCLETIS' ASC36_35FDC DEMONSTRATED POTENTIAL FOR ONCE-MONTHLY TO ONCE-QUARTERLY DOSING AND ROBUST WEIGHT-LOSS IN PRECLINICAL STUDIES PRESENTED AT EASD 2026

📄 Open the filing

Delete

No.2 Disclosure 2026/09/29 18:01

中間報告書
Interim Report 2026

📄 Open the filing

Delete

No.1 Disclosure 2026/09/29 08:50

事業の状況
VOLUNTARY ANNOUNCEMENT - ASCLETIS ANNOUNCES POSITIVE RESULTS FROM 28-DAY PROOF-OF-CONCEPT CLINICAL STUDY IN U.S. FOR ASC50, A FIRST-IN-CLASS AND BEST-IN-CLASS ORAL SMALL MOLECULE IL-17A INHIBITOR FOR THE TREATMENT OF PLAQUE PSORIASIS

📄 Open the filing

Delete

Write on the Ascletis Pharma Inc. board

More Chinese stocks in English

Chinese Stock Message Board: stocks available in English

01672 Ascletis Pharma Inc.ASCLETIS-BHong Kong Stock Exchange

Ascletis Pharma Inc. (01672) at a glance

Ascletis Pharma Inc. (01672) Stock Price History

Last 10 Trading Days

Last 10 Trading Days

Monthly Closes

Monthly Closes

Yearly Closes

Yearly Closes

Yearly Closes

Recent announcements (HKEXnews)

Posts

Write on the Ascletis Pharma Inc. board

More Chinese stocks in English

Other boards in English